Sudan vs Timor-Leste: HIV-positive TB patients on ART (antiretroviral therapy)
Sudan
94.0%
in 2024
Timor-Leste
95.0%
in 2024
Sudan rank
80th
Timor-Leste rank
79th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sudan
- Timor-Leste
How they compare
Timor-Leste currently reports 95.0% against 94.0% in Sudan, a difference of 1.0%.
The two have swapped places 2 times across 15 shared years of data; in 2008 it was Timor-Leste ahead.
Sudan ranks 80th and Timor-Leste ranks 79th of 144 countries.
Timor-Leste has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sudan | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.0% | 100.0% | 48.0% | Timor-Leste |
| 2010s | 63.6% | 96.2% | 32.7% | Timor-Leste |
| 2020s | 94.8% | 97.6% | 2.8% | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sudan or Timor-Leste?
- Timor-Leste, at 95.0% against 94.0% in Sudan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sudan and Timor-Leste?
- 1.0%, with Timor-Leste ahead.
- How many years of comparable data are there for Sudan and Timor-Leste?
- 15 years are reported by both, from 2008 to 2024.
- How do Sudan and Timor-Leste rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sudan ranks 80th and Timor-Leste ranks 79th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.